Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

UNITEDHEALTH GROUP

(UNH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

UnitedHealth Group : Increase of volatility

share with twitter share with LinkedIn share with facebook
share via e-mail
06/11/2019 | 03:56am EDT
long trade under condition
On stand-by
Entry price : 253$ | Target : 272$ | Stop-loss : 245$ | Cancellation Level : 237$ | Potential : 7.51%
UnitedHealth Group shares have recently experienced an upward movement with a return of higher volumes and volatility. This technical chart pattern suggests a continuation of the upward movement.
Investors should benefit from the breakout of the $ 253 level to target the $ 272.
Chart UNITEDHEALTH GROUP
Duration : Period :
UnitedHealth Group Technical Analysis Chart | MarketScreener
Full-screen chart
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
  • UnitedHealth Group accounts for 5.04 % of our USA Portfolio. A trade is currently open since 11/02/2015 with a purchase price of $ 119.36. Discover the other 19 stocks of the USA portfolio managed by the MarketScreener portfolio management team.

Strengths
  • Predictions on business development from analysts polled by Thomson-Reuters are tight. This results from either a good visibility into core activities or accurate earnings releases.
  • Historically, the company has been releasing figures that are above expectations.
  • Analysts covering this company mostly recommend stock overweighting or purchase.

Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 248.78.
  • Below the resistance at 248.78 USD, the stock shows a negative configuration when looking looking at the weekly chart.
Ratings chart
Subsector Managed Healthcare - NEC
1st jan.Capitalisation (M$)Investor Rating
UNITEDHEALTH GROUP-1.51%224 813
ANTHEM INC8.64%71 099
CIGNA CORP-16.59%57 074
HUMANA-12.10%33 802
CENTENE CORPORATION-7.11%21 421
WELLCARE HEALTH PLANS21.61%13 961
MOLINA HEALTHCARE, INC.24.70%9 088
MAGELLAN HEALTH INC15.10%1 569
Autres valeurs du secteur

Patrick Rejaunier
© Zonebourse.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2019 244 B
EBIT 2019 19 379 M
Net income 2019 13 582 M
Debt 2019 19 053 M
Yield 2019 1,60%
P/E ratio 2019 17,65
P/E ratio 2020 15,56
EV / Sales 2019 1,04x
EV / Sales 2020 0,95x
Capitalization 235 B
Upcoming event on UNITEDHEALTH GROUP
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 287 $
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
David Scott Wichmann Chief Executive Officer & Director
Stephen J. Hemsley Executive Chairman
John Franklin Rex Chief Financial Officer
Richard J. Migliori Chief Medical Officer & EVP-Medical Affairs
Richard T. Burke Non-Executive Chairman